FindTrial
Sign In

Mesenchymal Stem Cell Infusion

BIOLOGICAL6 trials

Sponsors

Christian Medical College, Vellore, India, University of Liege, Leiden University Medical Center, Jianming Tan, Institute of Hematology & Blood Diseases Hospital, China

Conditions

Graft vs Host DiseaseHematological MalignanciesImmune Effector Cell Associated HematotoxicityMesenchymal Stem Cell TransplantationOrgan TransplantationOsteochondritis of the Femoral Head

Early Phase 1

Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head
NCT00813267
Jianming TanOsteochondritis of the Femoral Head
Start: 2009-12-31End: 2015-08-31Updated: 2012-10-10
Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy
RecruitingNCT07212335
Institute of Hematology & Blood Diseases Hospital, ChinaImmune Effector Cell Associated Hematotoxicity
Start: 2025-10-01End: 2028-09-30Target: 15Updated: 2026-02-11

Phase 1

Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease
NCT00314483
Christian Medical College, Vellore, IndiaGraft vs Host Disease
Start: 2007-06-30End: 2008-06-30Target: 25Updated: 2007-07-06
Mesenchymal Stem Cells and Subclinical Rejection
CompletedNCT00734396
Leiden University Medical CenterOrgan Transplantation
Start: 2009-02-28End: 2012-12-31Updated: 2013-01-07
Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease
Not yet recruitingNCT07826676
Pontifícia Universidade Católica do ParanáGraft vs Host Disease, Mesenchymal Stem Cell Transplantation
Start: 2026-10-01End: 2028-10-01Target: 20Updated: 2026-09-17

Phase 2

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
CompletedNCT00504803
University of LiegeHematological Malignancies
Start: 2006-12-31End: 2010-12-31Target: 30Updated: 2011-09-02